Synopsis
Synopsis
0
EU WC
0
NDC API
0
VMF
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Omacor
2. Omega-3 Ethyl Ester 90
3. P-om3 Adjunct
1. 861006-80-6
2. Omacor
3. Coromega
4. Lotriga
5. Zodin
6. Ethyl (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoate Compound With Ethyl (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoate (1:1)
7. Omega-3 Acid Ethyl Esters
8. Omega-3-acid Ethyl Ester
9. Omega-3-acid Ethyl Esters
10. Chembl1200711
11. Tak-085
12. Omega-3-acid Ethyl Esters Type A
13. Icosapent (epa Ethyl Ester)
14. Doconexent (dha Ethyl Ester)
15. K-85
16. 4,7,10,13,16,19-docosahexaenoic Acid, Ethyl Ester, (4z,7z,10z,13z,16z,19z)-, Mixt. With (5z,8z,11z,14z,17z)-ethyl 5,8,11,14,17-eicosapentaenoate
17. Ethyl (4z,7z,10z,13z,16z,19z)-docosa-4,7,10,13,16,19-hexaenoate;ethyl (5z,8z,11z,14z,17z)-icosa-5,8,11,14,17-pentaenoate
Molecular Weight | 687.0 g/mol |
---|---|
Molecular Formula | C46H70O4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 31 |
Exact Mass | 686.52741071 g/mol |
Monoisotopic Mass | 686.52741071 g/mol |
Topological Polar Surface Area | 52.6 Ų |
Heavy Atom Count | 50 |
Formal Charge | 0 |
Complexity | 916 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 11 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Lovaza |
Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
Active Ingredient | Omega-3-acid ethyl esters |
Dosage Form | Capsule |
Route | Oral |
Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
Market Status | Prescription |
Company | Smithkline Beecham |
2 of 4 | |
---|---|
Drug Name | Omega-3-acid ethyl esters |
Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
Active Ingredient | Omega-3-acid ethyl esters |
Dosage Form | Capsule |
Route | Oral |
Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
Market Status | Prescription |
Company | Apotex; Teva Pharms Usa; Par Pharm |
3 of 4 | |
---|---|
Drug Name | Lovaza |
Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
Active Ingredient | Omega-3-acid ethyl esters |
Dosage Form | Capsule |
Route | Oral |
Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
Market Status | Prescription |
Company | Smithkline Beecham |
4 of 4 | |
---|---|
Drug Name | Omega-3-acid ethyl esters |
Drug Label | LOVAZA, a lipid-regulating agent, is supplied as a liquid-filled gel capsule for oral administration. Each 1-gram capsule of LOVAZA contains at least 900 mg of the ethyl esters of omega-3 fatty acids sourced from fish oils. These are predominantly a... |
Active Ingredient | Omega-3-acid ethyl esters |
Dosage Form | Capsule |
Route | Oral |
Strength | 1gm contains at least 900mg of the ethyl esters of omega-3 fatty acids |
Market Status | Prescription |
Company | Apotex; Teva Pharms Usa; Par Pharm |
Omega-3-Acid Ethyl Esters capsules, USP are indicated as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (500 mg/dL) hypertriglyceridemia (HTG).
FDA Label
Omega-3-acid ethyl esters reduce triglyceride production, increase fatty acid metabolism, inhibit the release of fatty acids, increase triglyceride clearance, and decrease production of very low density lipoprotein cholesterol(VLDL-C).
Absorption
Omega-3-acid ethyl esters are rapidly hydrolysed to free fatty acids in the intestinal lumen which then become incorporated into phospholipids, cholesterol, and triglycerides so determination of bioavailability by serum concentration is not possible.
Route of Elimination
Includes oxidative catabolism to carbon dioxide and water
Volume of Distribution
82 56L
Clearance
757 mL/h 283mL/h.
Omega-3-acid ethyl esters are hydrolysed to free fatty acids in the intestinal lumen by pancreatic lipase. Once in enterocytes, the free fatty acids are packaged in chylomicrons which are released from cells into the circulation. Fatty acids then enter the liver where they can be incorporated into liver stores, incorporated into lipoprotein phospholipids, or oxidised for energy.
79 hours 47 hours.
Omega-3-acid ethyl esters reduce triglyceride production by the liver but this mechanism is not well understood. Omega-3-acid ethyl esters inhibit acyl-CoA:1,2-diacylglycerol acyltransferase, reducing triglyceride synthesis and increasing paroxysmal beta-oxidation, which increases fatty aside metabolism. Omega-3-acid ethyl esters also inhibit the release of fatty acids by competing for enzymes involved in the synthesis of triglycerides, increase triglyceride clearance by increasing the activity of lipoprotein lipase, and decrease production of VLDL-C.
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
ABOUT THIS PAGE
A Omega-3-Acid Ethyl Esters 90 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Omega-3-Acid Ethyl Esters 90, including repackagers and relabelers. The FDA regulates Omega-3-Acid Ethyl Esters 90 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Omega-3-Acid Ethyl Esters 90 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Omega-3-Acid Ethyl Esters 90 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Omega-3-Acid Ethyl Esters 90 supplier is an individual or a company that provides Omega-3-Acid Ethyl Esters 90 active pharmaceutical ingredient (API) or Omega-3-Acid Ethyl Esters 90 finished formulations upon request. The Omega-3-Acid Ethyl Esters 90 suppliers may include Omega-3-Acid Ethyl Esters 90 API manufacturers, exporters, distributors and traders.
click here to find a list of Omega-3-Acid Ethyl Esters 90 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Omega-3-Acid Ethyl Esters 90 DMF (Drug Master File) is a document detailing the whole manufacturing process of Omega-3-Acid Ethyl Esters 90 active pharmaceutical ingredient (API) in detail. Different forms of Omega-3-Acid Ethyl Esters 90 DMFs exist exist since differing nations have different regulations, such as Omega-3-Acid Ethyl Esters 90 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Omega-3-Acid Ethyl Esters 90 DMF submitted to regulatory agencies in the US is known as a USDMF. Omega-3-Acid Ethyl Esters 90 USDMF includes data on Omega-3-Acid Ethyl Esters 90's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Omega-3-Acid Ethyl Esters 90 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Omega-3-Acid Ethyl Esters 90 suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Omega-3-Acid Ethyl Esters 90 Drug Master File in Japan (Omega-3-Acid Ethyl Esters 90 JDMF) empowers Omega-3-Acid Ethyl Esters 90 API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Omega-3-Acid Ethyl Esters 90 JDMF during the approval evaluation for pharmaceutical products. At the time of Omega-3-Acid Ethyl Esters 90 JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Omega-3-Acid Ethyl Esters 90 suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Omega-3-Acid Ethyl Esters 90 Drug Master File in Korea (Omega-3-Acid Ethyl Esters 90 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Omega-3-Acid Ethyl Esters 90. The MFDS reviews the Omega-3-Acid Ethyl Esters 90 KDMF as part of the drug registration process and uses the information provided in the Omega-3-Acid Ethyl Esters 90 KDMF to evaluate the safety and efficacy of the drug.
After submitting a Omega-3-Acid Ethyl Esters 90 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Omega-3-Acid Ethyl Esters 90 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Omega-3-Acid Ethyl Esters 90 suppliers with KDMF on PharmaCompass.
A Omega-3-Acid Ethyl Esters 90 CEP of the European Pharmacopoeia monograph is often referred to as a Omega-3-Acid Ethyl Esters 90 Certificate of Suitability (COS). The purpose of a Omega-3-Acid Ethyl Esters 90 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Omega-3-Acid Ethyl Esters 90 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Omega-3-Acid Ethyl Esters 90 to their clients by showing that a Omega-3-Acid Ethyl Esters 90 CEP has been issued for it. The manufacturer submits a Omega-3-Acid Ethyl Esters 90 CEP (COS) as part of the market authorization procedure, and it takes on the role of a Omega-3-Acid Ethyl Esters 90 CEP holder for the record. Additionally, the data presented in the Omega-3-Acid Ethyl Esters 90 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Omega-3-Acid Ethyl Esters 90 DMF.
A Omega-3-Acid Ethyl Esters 90 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Omega-3-Acid Ethyl Esters 90 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Omega-3-Acid Ethyl Esters 90 suppliers with CEP (COS) on PharmaCompass.
Omega-3-Acid Ethyl Esters 90 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Omega-3-Acid Ethyl Esters 90 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Omega-3-Acid Ethyl Esters 90 GMP manufacturer or Omega-3-Acid Ethyl Esters 90 GMP API supplier for your needs.
A Omega-3-Acid Ethyl Esters 90 CoA (Certificate of Analysis) is a formal document that attests to Omega-3-Acid Ethyl Esters 90's compliance with Omega-3-Acid Ethyl Esters 90 specifications and serves as a tool for batch-level quality control.
Omega-3-Acid Ethyl Esters 90 CoA mostly includes findings from lab analyses of a specific batch. For each Omega-3-Acid Ethyl Esters 90 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Omega-3-Acid Ethyl Esters 90 may be tested according to a variety of international standards, such as European Pharmacopoeia (Omega-3-Acid Ethyl Esters 90 EP), Omega-3-Acid Ethyl Esters 90 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Omega-3-Acid Ethyl Esters 90 USP).
LOOKING FOR A SUPPLIER?